2018
DOI: 10.1016/j.ejmech.2017.10.033
|View full text |Cite
|
Sign up to set email alerts
|

1,4-Naphthoquinones potently inhibiting P2X7 receptor activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(33 citation statements)
references
References 46 publications
1
32
0
Order By: Relevance
“…Compound (25) has significant anti-inflammatory properties that inhibit LPS-induced cytokine production in human mononuclear cell lines THP-1 and block the production of TNF-α and interleukin (IL)-6 with an IC 50 of 0.60 and 0.06 µM respectively, while (26) was inactive. 50) To date, a number of new 3-halogen and 3-aryl-2-hydroxy-1,4-naphthoquinones have been synthesized, among which a new class of effective inhibitors of P2X7 receptors has been established. 51) In fact, currently this is the first published work demonstrating the effective anti-inflammatory and analgesic activity of 1,4-naphthoquinones associated with the blocking of P2X7 receptors.…”
Section: Cardioprotective and Anti-ischemic Propertiesmentioning
confidence: 99%
“…Compound (25) has significant anti-inflammatory properties that inhibit LPS-induced cytokine production in human mononuclear cell lines THP-1 and block the production of TNF-α and interleukin (IL)-6 with an IC 50 of 0.60 and 0.06 µM respectively, while (26) was inactive. 50) To date, a number of new 3-halogen and 3-aryl-2-hydroxy-1,4-naphthoquinones have been synthesized, among which a new class of effective inhibitors of P2X7 receptors has been established. 51) In fact, currently this is the first published work demonstrating the effective anti-inflammatory and analgesic activity of 1,4-naphthoquinones associated with the blocking of P2X7 receptors.…”
Section: Cardioprotective and Anti-ischemic Propertiesmentioning
confidence: 99%
“…HEK-293 cells expressing human P2X7R were maintained in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Prolab, Br) and anti-biotics (50 U/ml penicillin and 50 mg/ml streptomycin) in a humidified 5% CO 2 atmosphere at 37°C (Faria et al, 2018). A total of 5 × 10 5 cells were plated at 37°C in a humidified 5% CO 2 atmosphere for 24 h in a 96-well plate for dye uptake or IL-1β release assays.…”
Section: Biological Assaysmentioning
confidence: 99%
“…The P2X7 receptor is a ligand-dependent ion channel that belongs to the type 2 purinergic receptor family (P2) [1]. The P2 receptor family comprises the P2Y G protein-coupled receptors (P2Y1, 2,4,6,[11][12][13][14] and the P2X (P2X1-7) receptors, which are ion channels regulated by ligand. P2X7 is the receptor subtype most widely studied from an immunological perspective [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…P2X7R inhibiting substances have been used as therapeutic agents [12,13]. However, clinical trials in patients with rheumatoid arthritis using AZD-9056 and CE-224535 showed no improvement in the disease compared to the current clinical treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation